| Literature DB >> 25309531 |
Vishvanath Tiwari1, Monalisa Tiwari1.
Abstract
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source. Moreover it resists desiccation. Carbapenems, a β-lactam, are the most commonly prescribed drugs against A. baumannii. Resistance against carbapenem has emerged in Acinetobacter baumannii which can create significant health problems and is responsible for high morbidity and mortality. With the development of quantitative proteomics, a considerable progress has been made in the study of carbapenem resistance of Acinetobacter baumannii. Recent updates showed that quantitative proteomics has now emerged as an important tool to understand the carbapenem resistance mechanism in Acinetobacter baumannii. Present review also highlights the complementary nature of different quantitative proteomic methods used to study carbapenem resistance and suggests to combine multiple proteomic methods for understanding the response to antibiotics by Acinetobacter baumannii.Entities:
Keywords: Acinetobacter baumannii; biofilm formation; carbapenem resistance; pathogenesis; quantitative proteomics
Year: 2014 PMID: 25309531 PMCID: PMC4176082 DOI: 10.3389/fmicb.2014.00512
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Differentially expressed proteins identified in the carbapenem resistance strain as compared to sensitive strain of .
| Carbapenem hydrolyzing beta-lactamase (AmpC and OXA) | Yes | Yes | Yes | Hydrolyze beta-lactams and carbapenem |
| Efflux pumps (AdeABC efflux pump, RND Family transporters) | Yes | Yes | Yes | Aids in the efflux of the antibiotics |
| Penicillin-binding protein (PBP6, PBP1b) | Yes | No | Yes | Synthesis of peptidoglycan, its alteration cause resistance |
| Outer membrane protein (OmpA) | No | Yes | Yes | Associated with non-specific transport |
| CarO protein | Yes | Yes | Yes | Involved in carbapenem resistance |
| Omp W | Yes | Yes | Yes | Down regulation in resistant strains decreases entry of antibiotics |
| Biofilm forming protein (Csu A/B) | Yes | Yes | Yes | CsuA/BABCDE chaperone-usher pili assembly system is require for biofilm formation |
| DcaP like protein | No | Yes | Yes | Associated with cell wall and membrane biogenesis, also have role in biofilm formation |
| Putative porin, OprD family | No | Yes | Yes | Involved in non-specific transport, also have role in biofilm formation |
| Signaling protein (tyrosine kinase) | N/D | N/D | Yes | Involved in novel two-component regulatory system which plays role in biofilm formation |
| Iron-binding protein Receptor (Siderophore receptor) | No | Yes | Yes | Involved in iron transport |
| Chaperonin | No | Yes | Yes | Aids in stress induced stabilization of protein |
| Peptidyl-prolyl cis-trans isomerase | N/D | Yes | Yes | Accelerates the folding of proteins by cis-trans isomerization of proline imidic peptide bonds |
| Regulatory protein (Elongation Factor Tu etc.) | Yes | Yes | Yes | Associated with protein synthesis |
| Energy producing enzymes (MDH, Aconitate hydratase, ATP synthase etc.) | No | Yes | Yes | Associated with energy production in the cell |
| Putative tonB-dependent receptor protein | Yes | N/D | Yes | Acts as TonB-dependent receptor for a non-iron nutrient source |
| ABC transporter | Yes | Yes | Yes | Associated with Phosphate and Amino acid transport |
| Lipoproteins | Yes | Yes | Yes | Involved in the adhesion and translocation of virulence factors in host cells |
| Superoxide dismutase | Yes | Yes | Yes | Destroy free radicals produced in the cell |
| Phosphor- | N/D | N/D | Yes | Involved in Cell wall synthesis |
| Cell division protein (zipA) | N/D | N/D | Yes | Involved in cell division |
| Putative universal stress protein family | N/D | N/D | Yes | Involved in the stress response |
No, No change; Yes, changed in the resistant strain as compared to sensitive strain; N/D, Not detected.
Different quantitative proteomic approaches with its merits and demerits.
| 2DE | (1) Simplistic | (1) Involve large amount of sample | Klose, |
| (2) Robust | (2) Low throughput | ||
| (3) Suitable for MS analysis | (3) Poor recovery of hydrophobic proteins | ||
| (4) High inter-gel variability | |||
| 2D-DIGE | (1) Multiplexing | (1) Expensive Cy dyes | Unlu et al., |
| (2) Better quantitation | (2) Poor recovery of hydrophobic proteins | ||
| (3) Minimized gel to gel variation | (3) Difficulty in separation of low molecular weight | ||
| SILAC | (1) High throughput | (1) Suitable only for tissue culture models | Ong et al., |
| (2) Robust | (2) Costly reagents | ||
| (3) Sensitive and simple | (3) Not applicable to tissue sample | ||
| ICAT | (1) Selectively isolates peptide | (1) Cannot identify proteins with less than 8 cysteines | Gygi et al., |
| (2) Compatible with any amount of protein | (2) Size of ICAT label is large (≈500Da) | ||
| (3) Complexity of the peptide mixture is reduced | (3) Post-translational modification information is frequently lost | ||
| iTRAQ | (1) Applicable to versatile samples | (1) Involve high amount of sample | Ross et al., |
| (2) Multiplexing | (2) Incomplete labeling | ||
| (3) Better quantitation | (3) Expensive reagents | ||
| ICPL | (1) High-throughput quantitative proteome profiling on a global scale | (1) Isotopic effect of deuterated tags that interferes with retention time of the labeled peptides during LC | Kellermann, |
| (2) Able to detect post-translational modifications and protein isoforms | |||
| (3) Applicable to protein sample like extracts from tissues or body fluids | |||
| Label-free | (1) Involve less amount of sample | (1) High throughput instrumentation | Mirza and Olivier, |
| (2) Higher proteome coverage | (2) Not suitable for low abundant proteins | ||
| (3) Avoid labeling | (3) Incomplete digestion may introduce error | ||
| (4) Multiplexed analysis is not possible in one experiment | |||
| SRM | (1) Highly sensitive, quantitatively accurate and highly reproducible | (1) Limited broad scale application because of difficulty of generating high-quality SRM assay. | Elschenbroich and Kislinger, |
| (2) Protein detection is relatively rapid and straightforward | (2) Sensitivity is not comparable to immunological assays | ||
| (3) Enable the detection of low (>10 ng/ml) abundance proteins | (3) Detection and quantification of low abundance proteins (i.e., ~ 10 ng/ml or less) | ||
| (4) Quantification of post-translational modification | |||